CBIO vs PVLA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

CBIO

31.4
AI Score
VS
PVLA Wins

PVLA

53.5
AI Score

Investment Advisor Scores

CBIO

31score
Recommendation
SELL

PVLA

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO PVLA Winner
Revenue 1.04M 29.01M PVLA
Net Income -48.12M -24.70M PVLA
Net Margin -4631.4% -85.1% PVLA
Operating Income -51.09M -25.83M PVLA
ROE -29.5% -119.6% CBIO
ROA -26.3% -21.2% PVLA
Total Assets 182.76M 116.75M CBIO
Cash 171.59M 46.07M CBIO
Current Ratio 9.66 2.46 CBIO
Free Cash Flow -28.56M -39.78M CBIO

Relative Price Performance (Last 90 Days)

CBIO 1M: +18.1% · 3M: +5.8% PVLA 1M: -3.2% · 3M: +41.1%

Current Technical Phase

CBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 58

RSI (14): 58.0 · Price: $19.41

PVLA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $150.13

Fundamentals Snapshot

Metric CBIO PVLA
Market Cap
Forward P/E -7.4 -20.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0%
Operating Margin -14.3% 0.0%
EPS -0.14 -4.83
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PVLA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.